Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Collagen Matrix Minimizes Post-Surgical Adhesions

By HospiMedica staff writers
Posted on 02 Feb 2007
A remodelable biomaterial minimizes post-surgical tissue attachment, a common and painful post-surgical complication. More...


The Veritas collagen matrix is an implantable, biomedical material that provides a scaffold for recellularization of the repaired tissue site. The tissue surfaces proximal to the repair are separated by a biomaterial provided in the form of a non-crosslinked, decellularized, and purified bovine pericardium into which the body's own tissue can grow, effectively remodeling the implant to the host tissue. The biomaterial effectively inhibits fibrosis, scar formation, and surgical adhesions.

The matrix is intended for use as an implant in the surgical repair of soft tissue deficiencies, including buttressing and reinforcing staple lines during lung resection and other incisions and excision of the lung and bronchus; reinforcement of the gastric staple line during bariatric surgical procedures; abdominal and thoracic wall repair; repair of hernias; and a range of other procedures. The Veritas collagen matrix is a product of Synovis Life Technologies (St. Paul, MN, USA) and has been approved by the U.S. Food and Drug Administration (FDA).

"Our versatile, remodelable Veritas is currently used in various applications, from gastric bypass and thoracic surgeries to pelvic floor reconstruction,” said Richard Kramp, president and CDEO of Synovis Life Technologies.



Related Links:
Synovis Life Technologies

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.